Enzyme replacement therapy for Gaucher disease.

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest (1994) 3.30

Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J Clin Invest (1994) 1.73

Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci U S A (1991) 1.63

Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1999) 1.53

Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J Clin Invest (1998) 1.20

Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet (1993) 1.16

Review of the safety and efficacy of imiglucerase treatment of Gaucher disease. Biologics (2009) 1.14

Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages. J Clin Invest (1993) 1.10

Imiglucerase in the treatment of Gaucher disease: a history and perspective. Drug Des Devel Ther (2012) 1.10

Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA. Am J Hum Genet (1992) 1.09

Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model. PLoS One (2010) 1.05

Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. Proc Natl Acad Sci U S A (1993) 1.03

Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease. J Inherit Metab Dis (1998) 0.94

Promising CNS-directed enzyme replacement therapy for lysosomal storage diseases. Exp Neurol (2009) 0.88

Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations. Proc Natl Acad Sci U S A (1995) 0.86

Enzyme replacement therapy for Gaucher's disease: the early Canadian experience. CMAJ (1998) 0.86

Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII. Proc Natl Acad Sci U S A (2012) 0.83

Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications. Orphanet J Rare Dis (2014) 0.83

Oligosaccharide excretion in adult Gaucher disease. J Inherit Metab Dis (1998) 0.82

Remaining problems in the management of patients with Gaucher disease. J Inherit Metab Dis (2001) 0.79

Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients. Orphanet J Rare Dis (2016) 0.79

Gaucher's disease and cancer: a sphingolipid perspective. Crit Rev Oncog (2013) 0.78

Carboxyl-terminal truncations alter the activity of the human α-galactosidase A. PLoS One (2015) 0.75

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy. Core Evid (2016) 0.75

Gaucher's disease type III C: Unusual cause of intracardiac calcification. Ann Pediatr Cardiol (2008) 0.75

Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J Virol (1984) 8.32

Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet (1992) 4.75

Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med (1991) 4.31

Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23

Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07

Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99

The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81

Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55

Photorefractoriness in birds and comparison with mammals. Physiol Rev (1988) 2.46

Polymyalgia rheumatica and temporal arteritis. Ann Rheum Dis (1966) 2.23

Regional distribution of ventilation and perfusion as a function of body position. J Appl Physiol (1966) 2.20

Routine histological examination of the mastectomy scar at the time of breast reconstruction: important oncological surveillance? Br J Plast Surg (2004) 2.14

Transposition of the Drosophila element mariner into the chicken germ line. Nat Biotechnol (1998) 2.09

A less costly regimen of alglucerase to treat Gaucher's disease. N Engl J Med (1992) 1.98

Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore) (1992) 1.96

Arthroplasty of the forefoot. J Bone Joint Surg Br (1967) 1.96

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol (2001) 1.94

Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol (1999) 1.91

Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone (2000) 1.89

Epithelial-myoepithelial carcinomas of the bronchus. Am J Surg Pathol (2001) 1.85

Variation in the expression of blood group antigen A in clonal cultures of rabbit cells. Exp Cell Res (1966) 1.85

Does routine intraoperative cholangiography prevent bile duct transection? Surg Endosc (2005) 1.85

Activity of respiratory pump and upper airway muscles during sleep onset. J Appl Physiol (1985) (1998) 1.74

2-Chlorodeoxyadenosine treatment of low-grade lymphomas. J Clin Oncol (1992) 1.65

The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) (2000) 1.64

Factors affecting the expression of blood group antigen A in cultured cells. Exp Cell Res (1967) 1.61

Peripheral T-cell lymphoma after anti-CD20 antibody therapy. J Clin Oncol (1998) 1.58

DNA-binding activity and subunit interaction of the mariner transposase. Nucleic Acids Res (2001) 1.55

Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum (1992) 1.51

What is the role of the research ethics committee? Paternalism, inducements, and harm in research ethics. J Med Ethics (2005) 1.47

The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J (1985) 1.45

Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia. Am J Clin Pathol (1994) 1.45

Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia. Br J Haematol (1998) 1.42

An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis. J Clin Gastroenterol (2000) 1.42

Intractable seizures in pregnancy. Lancet (1999) 1.40

From safety contract to safety agreement. J Psychosoc Nurs Ment Health Serv (2001) 1.39

Proposing a new standard to establish medical competence for the purpose of critical care intervention. Crit Care Med (2000) 1.39

TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med (2001) 1.38

Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemia. Mayo Clin Proc (1996) 1.38

Sequence analysis of the simian foamy virus type 1 genome. Gene (1991) 1.38

Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int (2000) 1.35

Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone (2002) 1.30

Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood (1993) 1.29

A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol (1972) 1.28

Respiratory instability during sleep onset. J Appl Physiol (1985) (1992) 1.24

Effect of age on sleep onset-related changes in respiratory pump and upper airway muscle function. J Appl Physiol (1985) (2000) 1.21

Disease activity and pregnancy associated alpha 2-glycoprotein in rheumatoid arthritis during pregnancy. Br Med J (Clin Res Ed) (1983) 1.20

Suicide and 'violent' death in a six-year cohort of male probationers compared with pattern of mortality in the general population: evidence of accumulative socio-psychiatric vulnerability. J R Soc Health (1997) 1.19

The ethics of mandatory vaccination against influenza for health care workers. Vaccine (2008) 1.19

Nuclear factor I is specifically targeted to discrete subnuclear sites in adenovirus type 2-infected cells. J Virol (1992) 1.15

Lifetime risk of hip fractures is underestimated. Osteoporos Int (1998) 1.15

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed (2001) 1.14

ECG abnormalities in co-proxamol (paracetamol/dextropropoxyphene) poisoning. Clin Toxicol (Phila) (2005) 1.14

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer (2001) 1.13

Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med (1993) 1.13

Plasma gonadal steroid levels in wild starlings (Sturnus vulgaris) during the annual cycle and in relation to the stages of breeding. Gen Comp Endocrinol (1983) 1.12

Treatment of anticholinergic-induced ileus with neostigmine. Ann Emerg Med (2001) 1.11

Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clin Genet (2007) 1.11

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. Br J Cancer (2001) 1.10

The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol (1998) 1.10

Plasma prolactin and gonadotrophins during gonadal development and the onset of photorefractoriness in male and female starlings (Sturnus vulgaris) on artificial photoperiods. J Endocrinol (1983) 1.09

Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 1.08

Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J Virol (1993) 1.08

Comment: serotonin syndrome and 5-HT2A antagonism. Ann Pharmacother (2001) 1.08

Farm visits and zoonoses. Commun Dis Rep CDR Rev (1995) 1.06

Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology. J Neurol Neurosurg Psychiatry (1989) 1.04

Infectious mononucleosis and mononucleosis syndromes. West J Med (1977) 1.02

Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res (1988) 1.02

Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood (1993) 1.01

Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides. Virology (1993) 1.01

Gender differences in airway resistance during sleep. J Appl Physiol (1985) (1997) 1.01

Intestinal carriage of verocytotoxigenic Escherichia coli O157, Salmonella, thermophilic Campylobacter and Yersinia enterocolitica, in cattle, sheep and pigs at slaughter in Great Britain during 2003. Epidemiol Infect (2007) 1.01

Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood (1994) 1.00

Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart. J Neurol Neurosurg Psychiatry (1968) 0.99

Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction. J Virol (1999) 0.99

Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast. J Clin Pathol (2000) 0.97

Effect of ribosomal protein L12 upon initiation factor IF-2 activities. Biochem Biophys Res Commun (1973) 0.97

Misuse of marrow examination in the diagnosis of Gaucher disease. Blood (1990) 0.96

Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology (1974) 0.95

Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Breast Cancer Res Treat (2010) 0.95

Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle. Virology (1998) 0.94

Decreased light intensity alters the perception of day length by male European starlings (Sturnus vulgaris). J Biol Rhythms (1998) 0.94

Flow cytometric determination of pre-transfusion red cell volume in fetuses and neonates requiring transfusion based on RhD+ dilution by transfused D- red cells. Br J Haematol (1995) 0.94

The effect of postpartum lactation counseling on the duration of breast-feeding in low-income women. Am J Dis Child (1990) 0.94

In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Virology (1991) 0.93

Linkage between a PvuII restriction fragment length polymorphism and G6PD A-202A/376G: evidence for a single origin of the common G6PD A- mutation. Hum Genet (1990) 0.93

Reproducibility of spirometric measurements in normal subjects. Am Rev Respir Dis (1966) 0.92

Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology (1990) 0.92

Effect and offset of effect of treatments for hip fracture on health outcomes. Osteoporos Int (1999) 0.92

Melorheostosis of the axial skeleton with associated fibrolipomatous lesions. Skeletal Radiol (1982) 0.91

Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector. J Gen Virol (2008) 0.91

Metachronous small-bowel adenocarcinoma in coeliac disease: gluten-free diet is not protective. Scand J Gastroenterol (1998) 0.91

Splenectomy for hairy cell leukemia in pregnancy. J Perinatol (1998) 0.90

Hypothalamic gonadotrophin-releasing hormone and pituitary and plasma FSH and prolactin during photostimulation and photorefractoriness in intact and thyroidectomized starlings (Sturnus vulgaris). J Endocrinol (1985) 0.90

Cell kinetics of a chondrosarcoma. Cell Tissue Kinet (1976) 0.90

Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer. J Biol Response Mod (1985) 0.90